PubMed

Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients.

Koh JH, Shin YG, Nam SM, Lee MY, Chung CH, Shin JY.

Diabetes Care. 2009 Jan;32(1):147-52. Epub 2008 Oct 3.PMID: 18835952 [PubMed - in process]Related articlesFree article

The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.

Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Son BH, Shin JH.

Metabolism. 2006 Dec;55(12):1604-9.PMID: 17142131 [PubMed - indexed for MEDLINE]Related articles

[Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?]

Graffigna MN, Belli SH, de Larrañaga G, Fainboim H, Estepo C, Peres S, García N, Levalle O.

Acta Gastroenterol Latinoam. 2009 Mar;39(1):30-7. Spanish. PMID: 19408737 [PubMed - indexed for MEDLINE]Related articles

Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.

Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC, Lam KS.

Circulation. 2007 Mar 27;115(12):1537-43.PMID: 17389279 [PubMed - indexed for MEDLINE]Related articlesFree article

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.

Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, Falezza G.

Clin Endocrinol (Oxf). 2006 Jun;64(6):679-83.PMID: 16712671 [PubMed - indexed for MEDLINE]Related articles

[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]

Choi SY, Kim D, Kang JH, Park MJ, Kim YS, Lim SH, Kim CH, Lee HS.

Korean J Hepatol. 2008 Mar;14(1):77-88. Korean. PMID: 18367860 [PubMed - indexed for MEDLINE]Related articlesFree article

Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.

Targher G, Bertolini L, Rodella S, Zoppini G, Zenari L, Falezza G.

Clin Endocrinol (Oxf). 2006 Mar;64(3):337-41.PMID: 16487446 [PubMed - indexed for MEDLINE]Related articles

A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients.

Ma YH, Zhao L, Xian XD, Yang D, Huang W, Wang YH, Mueller O, Chang E, Konigshofer Y, Van-Cleve M, Liu G, Yang JK.

Clin Chem Lab Med. 2009;47(9):1067-72.PMID: 19728847 [PubMed - indexed for MEDLINE]Related articles

Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.

Sung KC, Ryan MC, Kim BS, Cho YK, Kim BI, Reaven GM.

Diabetes Care. 2007 Aug;30(8):2113-8. Epub 2007 May 2.PMID: 17475935 [PubMed - indexed for MEDLINE]Related articlesFree article

Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men.

Park SH, Kim BI, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Kim H, Keum DK, Kim HD, Park JH, Kang JH, Jeon WK.

J Am Coll Nutr. 2007 Aug;26(4):321-6.PMID: 17906183 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Wu H, Jia W, Bao Y, Lu J, Zhu J, Wang R, Chen Y, Xiang K.

Diabetes Res Clin Pract. 2008 Feb;79(2):185-90. Epub 2007 Sep 29.PMID: 17904683 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

Meis SB, Schuster D, Gaillard T, Osei K.

Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.

Yoo J, Lee S, Kim K, Yoo S, Sung E, Yim J.

Diabetes Res Clin Pract. 2008 Sep;81(3):321-6. Epub 2008 Jun 20.PMID: 18571268 [PubMed - indexed for MEDLINE]Related articles

Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children.

Yun KE, Kim SM, Choi KM, Park HS.

Metabolism. 2009 Jun;58(6):798-802.PMID: 19368945 [PubMed - indexed for MEDLINE]Related articles

Hypoadiponectinemia and insulin resistance are associated with nonalcoholic fatty liver disease.

Yoon D, Lee SH, Park HS, Lee JH, Park JS, Cho KH, Kim SM.

J Korean Med Sci. 2005 Jun;20(3):421-6.PMID: 15953863 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

Park SH, Kim BI, Yun JW, Kim JW, Park DI, Cho YK, Sung IK, Park CY, Sohn CI, Jeon WK, Kim H, Rhee EJ, Lee WY, Kim SW.

J Gastroenterol Hepatol. 2004 Jun;19(6):694-8.PMID: 15151626 [PubMed - indexed for MEDLINE]Related articles

Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels.

Jiang LL, Li L, Hong XF, Li YM, Zhang BL.

Eur J Gastroenterol Hepatol. 2009 Jun;21(6):662-6.PMID: 19282764 [PubMed - in process]Related articles

Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.

Tso AW, Xu A, Sham PC, Wat NM, Wang Y, Fong CH, Cheung BM, Janus ED, Lam KS.

Diabetes Care. 2007 Oct;30(10):2667-72. Epub 2007 Jul 9.PMID: 17620449 [PubMed - indexed for MEDLINE]Related articlesFree article

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS.

Clin Chem. 2006 Mar;52(3):405-13. Epub 2006 Jan 19.PMID: 16423904 [PubMed - indexed for MEDLINE]Related articlesFree article

Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.

Dupuy AM, Jaussent I, Lacroux A, Durant R, Cristol JP, Delcourt C.

Gerontology. 2007;53(6):329-39. Epub 2007 Jun 5.PMID: 17551260 [PubMed - indexed for MEDLINE]Related articles